Rivera, Ava .

HRN: 19-65-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
AMPICILLIN 250MG (VIAL)
07/10/2022
07/17/2022
IV
200mg
Q6h
URTI
Waiting Final Action 
07/10/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/10/2022
07/17/2022
ORAL
5ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: